Objective Measurement of Adherence to Out-Patient Airway Clearance Therapy by High-Frequency Chest Wall Compression in Cystic Fibrosis

被引:14
作者
Mikesell, Christina L. [1 ,2 ,3 ]
Kempainen, Robert R. [4 ,5 ]
Laguna, Theresa A. [2 ,3 ]
Menk, Jeremiah S. [6 ]
Wey, Andrew R. [6 ]
Gaillard, Philippe R. [7 ]
Regelmann, Warren E. [2 ,3 ]
机构
[1] Childrens Resp & Crit Care Specialists, Minneapolis, MN USA
[2] Univ Minnesota, Cyst Fibrosis Ctr, Pediat Pulmonol, Minneapolis, MN USA
[3] Masonic Childrens Hosp, Minneapolis, MN USA
[4] Hennepin Cty Med Ctr, Pulm & Crit Care Med, Minneapolis, MN USA
[5] Univ Minnesota, Cyst Fibrosis Ctr & Hosp, Minneapolis, MN USA
[6] Univ Minnesota, Clin & Translat Sci Inst, Minneapolis, MN USA
[7] Auburn Univ, Dept Math & Stat, Auburn, AL 36849 USA
关键词
adherence; cystic fibrosis; high-frequency chest wall compression; pulmonary function test; pulmonary exacerbation; PULMONARY EXACERBATIONS; MEDICATION ADHERENCE; SELF-REPORT; CHILDREN; ADULTS; ADOLESCENTS; HEALTH;
D O I
10.4187/respcare.05349
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: Objective measures of adherence to high-frequency chest wall compression (HFCWC), a form of airway clearance therapy for patients with cystic fibrosis, are lacking. We used a novel electronic monitoring device integrated into an HFCWC vest to measure adherence compared with self-reported adherence. We determined factors that influenced adherence and how adherence correlated with baseline pulmonary function and pulmonary exacerbations. METHODS: Data were collected by direct measurement of date, time of day, and duration of HFCWC use to determine the number of daily treatments and daily duration of treatments. Chart review provided prescribed airway clearance therapy treatment and demographic and clinical information. Subject and caregiver report of the daily number of airway clearance therapy treatments was obtained by telephone interviews. Analysis used 2-sample and paired t test, analysis of variance, and linear regression. RESULTS: Average adherence was 69%. Adherence was highest in children (82%, P = .02) and those receiving assistance with treatment (82%, P < .001). Subjects overestimated therapy duration from a mean +/- SD of 127 +/- 169% by adults to 19.2 +/- 26.3% by parents or guardians of children. Average adherence decreased with increasing prescribed therapy time (P = .02). Average daily therapy time and adherence had significant positive associations with baseline FEV1 percent of predicted (P = .02 and P = .02, respectively) and negative associations with pulmonary exacerbations during the pre-study period and at baseline (P = .044 and P = .02, respectively). CONCLUSIONS: Greater adherence to HFCWC measured directly by a novel recorder was associated with better baseline pulmonary function and fewer exacerbations in the pre-study and baseline period. Adherence decreased with age and prescribed therapy time and increased with therapy assistance. Self-report overestimation is large and thus not an accurate measure of adherence.
引用
收藏
页码:920 / 927
页数:8
相关论文
共 31 条
  • [1] [Anonymous], 2003, Adherence to Long-Term Therapies: Evidence for action
  • [2] Treatment compliance in children and adults with Cystic Fibrosis
    Arias Llorente, Rosa Patricia
    Bousono Garcia, Carlos
    Diaz Martin, Juan Jose
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2008, 7 (05) : 359 - 367
  • [3] Adherence to nebulised therapies in adolescents with cystic fibrosis is best on week-days during school term-time
    Ball, Rosemary
    Southern, Kevin W.
    McCormack, Pamela
    Duff, Alistair J. A.
    Brownlee, Keith G.
    McNamara, Paul S.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2013, 12 (05) : 440 - 444
  • [4] Parental Depression and Pancreatic Enzymes Adherence in Children With Cystic Fibrosis
    Barker, David H.
    Quittner, Alexandra L.
    [J]. PEDIATRICS, 2016, 137 (02)
  • [5] Measurement of children's asthma medication adherence by self report, mother report, canister weight, and Doser CT
    Bender, B
    Wamboldt, FS
    O'Connor, SL
    Rand, C
    Szefler, S
    Milgrom, H
    Wamboldt, MZ
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2000, 85 (05) : 416 - 421
  • [6] Strategies to optimize treatment adherence in adolescent patients with cystic fibrosis
    Bishay, Lara C.
    Sawicki, Gregory S.
    [J]. ADOLESCENT HEALTH MEDICINE AND THERAPEUTICS, 2016, 7 : 117 - 124
  • [7] Adherence with tobramycin inhaled solution and health care utilization
    Briesacher, Becky A.
    Quittner, Alexandra L.
    Saiman, Lisa
    Sacco, Patricia
    Fouayzi, Hassan
    Quittell, Lynne M.
    [J]. BMC PULMONARY MEDICINE, 2011, 11
  • [8] Accuracy of children's self-reported adherence to treatment
    Burkhart, PV
    Dunbar-Jacob, JM
    Rohay, JM
    [J]. JOURNAL OF NURSING SCHOLARSHIP, 2001, 33 (01) : 27 - 32
  • [9] Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age
    Byrnes, Catherine Ann
    Vidmar, Suzanna
    Cheney, Joyce L.
    Carlin, John B.
    Armstrong, David S.
    Cooper, Peter J.
    Grimwood, Keith
    Moodie, Marj
    Robertson, Colin F.
    Rosenfeld, Margaret
    Tiddens, Harm A.
    Wainwright, Claire E.
    [J]. THORAX, 2013, 68 (07) : 643 - 651
  • [10] Accurate Assessment of Adherence Self-Report and Clinician Report vs Electronic Monitoring of Nebulizers
    Daniels, Tracey
    Goodacre, Lynne
    Sutton, Chris
    Pollard, Kim
    Conway, Steven
    Peckham, Daniel
    [J]. CHEST, 2011, 140 (02) : 425 - 432